ARCHIVES

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

This article is from The Cancer Letter archive.

Vol. 32 No. 8 | August 28, 2009

Download PDF Visit The Full Archive

Related Articles

New Firm Steps Onto Texas Battleground for Control Over Office-Based Oncology

November 22, 1996

Columbia Next for comprehensive Center Review

February 18, 1977

In Brief: Hammer Hears A Claim for The $1 Million Wynder’s Theory On Japan’s Colon Cancer Rates: Hamburgers

March 19, 1982

FY99 Appropriations: Congress Tells NCI To Fund More Research In Prostate Cancer

October 30, 1998

Survivorship Studies Unfocused As Total Research Increases

November 25, 2011

Adjuvant Chemo Improves Survival In Early Lung Cancer

July 30, 2004